For instance, in the clinical trial for obesity treatment, retatrutide also led to greater reductions in both systolic and diastolic blood pressure than placebo [57]
Wegovy (Semaglutide): Purpose: Specifically approved for weight management in individuals with obesity or overweight (BMI 30 or BMI 27 with a weight-related condition)
however, coverage varies by insurance plan, whether you meet the eligibility criteria, and the pharmacy you use, and it may require prior authorization from your insurance
Close follow-up helps manage dosage, side effect mitigation, and long-term planning
Biochimica et Biophysica Acta, 1790(10), 1149-1160
So, if youre looking for a more cost-effective weight loss option, Wegovy may be more suitable for you